Barry Buckland Joins Ancora Pharmaceuticals Board

MEDFORD, Mass.--(BUSINESS WIRE)--Ancora Pharmaceuticals Inc. announced today that Barry C. Buckland, Ph.D has joined the company’s Board of Directors. A former research and development executive at Merck Research Laboratories, Buckland brings a wealth of experience to Ancora. While at Merck, he participated in the development of a wide range of ground breaking products, including Merck’s landmark HPV vaccine GARDASIL®.